H&Q Asia Pacific
VC Fund
Palo Alto, United States
H&Q Asia Pacific (H&QAP) is a leading Asian private equity firm. Originally founded by Dr. Ta-lin Hsu as a division of U.S. investment banking firm Hambrecht & Quist, H&QAP is currently an independent organization that conducts both later-stage control investments and earlier-stage venture capital investments. It focuses on growthsectors including technology, technology manufacturing, consumer brands and financial services. The firm's offices are located in the principal markets of Asia as well as in the Silicon Valley, providing it with a unique combination of local market presence and global perspective. H&QAP is dedicated to identifying superior commercial potential in Asia and working closely with companies to unlock that untapped potential. Throughout its rich history, H&QAP has developed an extensive network specifically geared towards helping its portfolio companies emerge into global business leaders.
- Total investments:
- 44
- Last investment:
- Lead investor:
- 36%
Last updated:
For AI agents: llms.txt
Industries H&Q Asia Pacific invests in
Stages H&Q Asia Pacific invests in
Countries H&Q Asia Pacific invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 8 contacts → | |||
Round size
- Series A
- $5.3M–$31M
- Series B
- $7.5M–$50M
- Series C
- $7.9M–$85M
Investment Focus
Industry
- Information Technology 9 (20%)
- Software 8 (18%)
- Manufacturing 6 (14%)
- Biotechnology 5 (11%)
- Hardware 4 (9%)
Stage
- Series A 12 (27%)
- Series B 11 (25%)
- Series C 9 (20%)
- Funding Round 5 (11%)
- Series F 2 (5%)
Country
- United States 23 (52%)
- China 5 (11%)
- Taiwan 2 (5%)
- Hong Kong 2 (5%)
- Singapore 2 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Robert Shen
Managing Director
|
Managing Director | Total investments: 1 | Find email | |
|
Benson He
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
|
Jong Won Lee
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
|
Jung Jin Lee
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
|
Mark Hsu
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Ceres, Inc. (Ceres) is an agricultural biotechnology company selling seeds to produce renewable biomass feedstocks. The Company’s large-scale commercial products are sweet sorghum varieties that can be used as a drop-in feedstock to extend the operating season of Brazilian sugarcane-to-ethanol mills. Its products include sweet sorghum, high biomasssorghum, switchgrass, miscanthus and row crops. Its energy crops can also be used for the production of second-generation biofuels and bio-based chemicals, including cellulosic ethanol, butanol, jet fuel, diesel-like molecules and gasoline-like molecules, from non-food biomass. Baseload utility scale electric power can also be generated from the biomass feedstocks grown from its seeds. Ceres has sold switchgrass and high biomass sorghum seeds in the United States under its Blade Energy Crops (Blade) brand. In January 2010, the Company incorporated a subsidiary, Ceres Sementes do Brasil Ltda. | Series F / Sep 27, 2021 | ||
| Ceres applies genetic research and trait development to improve crop productivity, enhance quality characteristics, and support cultivation under varied environmental conditions. Its technology portfolio includes DNA-based trait solutions designed for integration across multiple crop types and end markets. Ceres also provides bioinformaticscapabilities through its Persephone software, which enables structured exploration and analysis of genomic data. | Series F / Sep 27, 2021 | ||
| FST Network's Virtual Assistive Data Officer provides a low-code platform to help Data Users to create new logics for each data processes with labelling functionalities. FST Network's Virtual Assistive Data Officer also comes with a search engine functionality to help Enterprises to find correlation of their data, getting full overview& lineage of Enterprises's data & system. | $2.9M / Seed / May 15, 2021 | ||
| Formosa Pharmaceuticals is a biopharmaceutical firm that specializes in ophthalmology and oncology. | $21.2M / Series C / Apr 16, 2021 | ||
| EOC Pharma is an integrated biopharmaceutical company that is focused on the manufacturing, development and commercialization of innovative global oncology products in China. They have adopted a licensing model in order to build EOC’s innovative pipeline by plugging their partner’s molecule into EOC’s “core engine” of local manufacturing,clinical development, regulatory filing, and commercialization. The company has a pipeline of seven novel products from global biopharmaceutical partners that are potentially first- and best-in-class. Until now, EOC has obtained four Class I innovative drug CTA approvals and initiated clinical studies of four lead products in China.,EOC has a team of entrepreneurs and consultants with overseas background that boasts of first-class pharmaceutical R&D expertise as well as rich industry experience. The company owns an 8,000 square meter cGMP manufacturing facility in Taizhou, China Medical City and has offices in Shanghai, Beijing, Hong Kong and Los Angeles.EOC will leverage forward-looking licensing which will provide product opportunities to their integrated platform, generating a highly strategic portfolio. Ultimately, this will position EOC at the top of oncology innovation in China. | $32M / Series B / Nov 07, 2017 | ||
| MoneyHero Group is a fintech company that focuses on personal finance aggregation and comparison, aiming to empower individuals for a better financial future. The company's key pillars include Personal Finance Platforms and B2B Business, fostering partnerships with Creatory Channel Partners and Content Creators under eKos_connect. MoneyHeroGroup shapes the future of finance through technology and connectivity. | $50M / Series B / Jul 12, 2017 | ||
| Hyphen Group is a network of finance companies. They empower and connect people to a better financial future through innovative tools, personalized digital experiences, and expert insights, and accelerate the digitization of the financial industry. | $50M / Series B / Jun 01, 2017 | ||
| One Inc provides insurance companies a digital payments platform designed to increase retention, decrease admin expenses, and mitigate data security risk – while simplifying compliance. The One Inc Digital Payments Platform combines multi-channel digital communications with electronic payment processing and disbursement, creating a frictionlesspremiums and claims payments experience. As one of the fastest growing digital payments platforms in the insurance industry, One Inc manages billions of dollars per year in premiums and claims payments. For more information, please visit www.oneincsystems.com. | $20M / Series B / Dec 14, 2016 | ||
| One is a technology company that specializes in digital payment solutions for the insurance industry. It develops digital payments software that combines inbound and outbound payment capabilities with industry-specific reporting and reconciliation along with a host of functions including policy administration, rating and billing with dataanalytics, customer relationship management (CRM), payment processing and agency management. | $20M / Series B / Dec 14, 2016 | ||
| Viscovery is a leading Vision Artificial Intelligence company based on Deep Learning and Computer Vision technology. Our revolutionary visual discovery service provides image and video recognition solutions for enterprises. Established in 2013, Viscovery has collaborated with Intel, NVIDIA, AWS, and received international recognition and investmentfrom Intel, Alibaba, Quanta, CDIB, H&Q, etc.Viscovery is dedicated to providing comprehensive recognition solutions for Smart Retail, Smart E-Commerce, Smart Media, Augmented Reality, Smart Factory and more. With our R&D team based in Taipei and consisting of computer scientists and engineers with expertise in Artificial Intelligence, Computer Vision, Machine Learning and Deep Learning, Viscovery has been exploring the unlimited possibilities via Vision AI, and providing customized recognition solutions for enterprises. (www.viscovery.com) | $10M / Venture - Series Unknown / Oct 18, 2016 | ||
| See all 44 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does H&Q Asia Pacific invest in?
H&Q Asia Pacific invests primarily in Information Technology, Software and Manufacturing startups, most often at Series A and Series B stage. Most of the 44 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is H&Q Asia Pacific's check size?
H&Q Asia Pacific typically joins rounds of $5.3M–$31M at Series A, $7.5M–$50M at Series B and $7.9M–$85M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds H&Q Asia Pacific participates in.
How do I contact H&Q Asia Pacific?
Public channels for H&Q Asia Pacific include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at H&Q Asia Pacific?
The team at H&Q Asia Pacific includes Robert Shen (Managing Director), Benson He (Managing Director) and Jong Won Lee (Managing Director), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
